Point Of Care Hiv Nat Diagnostic And/Or Supplemental Test
QSV is the FDA product code for Point Of Care Hiv Nat Diagnostic And/Or Supplemental Test, a class II device type, regulated under 21 CFR 866.3957. FDA's definition for this code reads: "Human immunodeficiency virus (HIV) Point of Care nucleic acid diagnostic and supplemental tests are prescription devices for the qualitative detection of HIV nucleic acid in human body fluids or tissues". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- QSV
- Device name
- Point Of Care Hiv Nat Diagnostic And/Or Supplemental Test
- FDA definition
- Human immunodeficiency virus (HIV) Point of Care nucleic acid diagnostic and supplemental tests are prescription devices for the qualitative detection of HIV nucleic acid in human body fluids or tissues.
- Regulation
- 21 CFR 866.3957
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code QSV.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
